Chinese medical journal
-
Chinese medical journal · Apr 2022
A broadly neutralizing human monoclonal antibody against the hemagglutinin of avian influenza virus H7N9.
The new emerging avian influenza A H7N9 virus, causing severe human infection with a mortality rate of around 41%. This study aims to provide a novel treatment option for the prevention and control of H7N9. ⋯ The mAb 6-137 could be an effective antibody as a prophylactic or therapeutic biological treatment for the H7N9 exposure or infection.
-
Chinese medical journal · Apr 2022
Review Meta AnalysisEndoscopic sleeve gastroplasty: a narrative review on historical evolution, physiology, outcomes, and future standpoints.
Since its first description in 2013, robust evidence supporting the efficacy and safety of the endoscopic sleeve gastroplasty (ESG) has been on the rise. A large case series and meta-analysis report supported results up to 24 months, while some other studies already described 5-year data. If associated with pharmacotherapy, the ESG may help one to achieve weight loss similar to that of surgical sleeve gastrectomy. Though the results of the ongoing randomized trials on ESG are awaited, currently available data support the clinical use of the ESG, especially for patients who are refusing or unfit for bariatric surgery.